Med24
diabetes 26. 12. 2026 • 2 min read • U.S. Food and Drug Administration (OpenFDA)

Levetiracetam Levetiracetam Injection Levetiracetam Levetira: FDA Clinical Pharmacology, Indications and Prescribing Update

1 INDICATIONS AND USAGE Levetiracetam injection is indicated for adjunctive therapy, as an alternative when oral administration is temporarily not feasible, in the treatment of: Partial onset seizures in patients 1 month of age and older with epilepsy (1.1) Myoclonic seizures in patients 12 years of age and older with...

Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

Levetiracetam injection is indicated for adjunctive therapy as an alternative when oral administration is not feasible. It is used to treat partial onset seizures in patients one month of age and older with epilepsy, myoclonic seizures in patients 12 years and older with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures in patients six years and older with idiopathic generalized epilepsy.

Mechanism of Action

The precise mechanism of action is unknown. Animal studies show levetiracetam protects against secondary generalized activity from focal seizures, and inhibits burst firing in the hippocampus. In vitro studies demonstrate that levetiracetam opposes the activity of negative modulators of GABA- and glycine-gated currents and partially inhibits N-type calcium currents. A saturable and stereoselective neuronal binding site for levetiracetam has been identified as the synaptic vesicle protein SV2A, which correlates with the drug’s antiseizure activity.

Sponsored content

Dosage and Administration

Clinical studies utilizing oral formulations have established levetiracetam’s effectiveness as adjunctive therapy in adults with refractory partial onset seizures. Dosage is individualized, with typical intravenous administration ranging from 500 to 1,500 mg every 12 hours, adjusted based on seizure frequency and patient condition. Supplemental doses are recommended for patients undergoing dialysis.

Original Scientific Source
U.S. Food and Drug Administration (OpenFDA)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement